Regular Article
The Ah Receptor Recognizes DNA Binding Sites for the B Cell Transcription Factor, BSAP: A Possible Mechanism for Dioxin-Mediated Alteration of CD19 Gene Expression in Human B Lymphocytes

https://doi.org/10.1006/bbrc.1995.1931Get rights and content

Abstract

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits murine and human B lymphocyte immunoglobulin production through an unknown mechanism. This study investigated the effect of TCDD on expression of the CD19 gene in a human B lymphocyte cell line. Northern blot analysis showed that TCDD treatment decreased steady state levels of CD19 mRNA by 67% in the IM-9 cell line. Using a gel mobility shift assay, we identified a DNA-binding complex in IM-9 nuclear extracts that by several criteria appears to be the Ah receptor. In addition, the Ah receptor complex recognized a DNA binding site for B cell lineage-specific activator protein (BSAP) in the promoter region of the human CD19 gene which is similar to the consensus Ah receptor DNA binding site. These results suggest that the AhR could interfere with BSAP-stimulated CD19 gene transcription by competition for a common DNA binding site.

References (0)

Cited by (34)

  • Immunotoxicology of Halogenated Aromatic Hydrocarbons

    2018, Comprehensive Toxicology: Third Edition
  • A single mid-gestation exposure to TCDD yields a postnatal autoimmune signature, differing by sex, in early geriatric C57BL/6 mice

    2011, Toxicology
    Citation Excerpt :

    Functional or other changes in bone marrow B-lineage cells that may accompany these alterations in phenotypic distribution have not been studied but may be important. The molecular pathways controlling B cell lymphopoiesis, B-cell receptor (BCR) positive and negative selection processes, and B cell trafficking from bone marrow are mediated by several different bone marrow-level signal-transduction pathways (Monroe et al., 2003) and related proteins (e.g., NFκB, CD22, and CD19), which are affected by inappropriate activation of the aryl hydrocarbon receptor (AhR) (Masten and Shiverick, 1995; Tian et al., 1999). It is not yet known if these B cell pathways may be altered by prenatal TCDD and contributes to the observed autoimmune phenotype.

  • Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage

    2011, Toxicology
    Citation Excerpt :

    It has been documented that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of IgM response is mediated through the activated AHR (Sulentic et al., 1998; Vorderstrasse and Kerkvliet, 2001). Masten and Shiverick (1995) showed that AHR negatively regulates Pax-5 (B cell lineage-specific activator protein)-stimulated CD19 gene transcription by competing to bind a common DNA binding site in human lymphocyte cell line treated with TCDD. A more recent study by De Abrew et al. (2010) identified 11 transcription factors and several genes known to regulate B-cell differentiation as targets of AHR in mouse B-cell line CH12.LX in response to TCDD exposure.

  • A constitutively active aryl hydrocarbon receptor causes loss of peritoneal B1 cells

    2003, Biochemical and Biophysical Research Communications
    Citation Excerpt :

    Although expression of CA-AhR in some way may be directly toxic to the CD5+ B1 cells, it is also possible that the CA-AhR can interfere with antigen receptor signaling. Interestingly, it has been shown that the Ah receptor ligand TCDD causes reduced expression of CD19 in a human B cell line [28]. Therefore, we have investigated CD19 expression on peripheral and bone marrow-derived B cells of adult CA-AhR mice as well as in livers from newborn mice.

View all citing articles on Scopus
View full text